Filter
292
Filtered Results: 292
Text search:
inactivated
vaccines
Featured
Recommendations
35
New Publications
83
Language
Document type
No document type
129
Guidelines
75
Studies & Reports
37
Fact sheets
18
Manuals
17
Strategic & Response Plan
7
Situation Updates
5
Training Material
3
Resource Platforms
1
Countries / Regions
Global
10
India
9
Pakistan
8
Germany
8
South Africa
7
Sierra Leone
6
Nigeria
6
Philippines
6
Afghanistan
5
Syria
5
Tanzania
5
Latin America and the Carribbean
5
Uganda
4
Kenya
4
Ukraine
4
Chile
4
Ethiopia
3
Nepal
3
Africa
3
Liberia
2
Congo, Democratic Republic of
2
Rwanda
2
Namibia
2
Myanmar / Burma
2
Yemen
2
East and Southern Africa
2
Middle East and North Africa
2
South–East Asia Region
2
Venezuela
2
Zimbabwe
1
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Zambia
1
Turkey
1
Egypt
1
China
1
Bangladesh
1
Malawi
1
Papua New Guinea
1
Argentina
1
Peru
1
Brazil
1
Colombia
1
Ecuador
1
Botswana
1
Bolivia
1
Libya
1
West and Central Africa
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Paraguay
1
Solomon Islands
1
Bhutan
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
82
Clinical Guidelines
41
Women & Child Health
14
Key Resources
7
Public Health
6
Pharmacy & Technologies
6
Capacity Building
1
Toolboxes
COVID-19
73
Polio
29
Rapid Response
20
Ebola
13
Pharmacy
13
Refugee
10
HIV
10
TB
10
NTDs
10
AMR
8
Cholera
7
Conflict
7
Zika
4
Natural Hazards
3
Planetary Health
3
Mental Health
2
Specific Hazards
1
Global Health Education
1
Health Financing Toolbox
1
NCDs
1
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed
to support decision making. A countrywide mass vaccination campaign with the
use of an ina... severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021.
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera...
Clinical Medicine
JCI Insight. 2017;2(7):e91963.
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to th...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strateg...
This article is part four in a series of explainers on vaccine development and distribution.
Part one focused on how vaccines work to protect our bodies from disease-carrying germs.
Part two focused on the ingredients in a vaccine and the three cl...
This is an e-learning module with the objective of providing education for health professionals and pregnant women using published results and studies based on COVID-19 surveillance data, which have indicated an increased risk among pregnant women of presenting with severe forms of COVID-19 and, the...
an approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity, and vaccine access and coverage scenarios, first issued 20 October 2020, updated: 13 November 2020, updated: 16 July 2021, late...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr...
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedn...
